Q: Please comment on the latest earnings and whether it is a good buy now, bearing in mind the sector it is in and speculative in nature. Thanks
Q: The marijuana business is not really my “thing”; however, this firm’s recent results are confounding my preconceptions on the state of the “weed scene”. Are they worth further analysis?